NanoViricides
NNVC
37 hedge funds and large institutions have $1.74M invested in NanoViricides in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.
5,100% more call options, than puts
Call options by funds: $104K | Put options by funds: $2K
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
3% more funds holding
Funds holding: 36 → 37 (+1)
0.66% less ownership
Funds ownership: 10.16% → 9.5% (-0.66%)
17% less capital invested
Capital invested by funds: $2.09M → $1.74M (-$349K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$65K |
| 2 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$63.5K |
| 3 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$28.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$14.3K |
| 5 |
NS
NBC Securities
Birmingham,
Alabama
|
+$4.31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$50.6K |
| 2 |
VF
Virtu Financial
New York
|
-$45.6K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$28.2K |
| 4 |
IWC
Integrated Wealth Concepts
Waltham,
Massachusetts
|
-$15.2K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$5.22K |
NNVC Hedge Fund Activity: Q1 2025 in Review
37 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q1 2025, worth a combined $1.74M — down 17% from $2.09M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NNVC positions and 2 closed out — a net gain of 1 holder — while 7 added to existing stakes and 5 trimmed.
The largest buyer was XTX Topco, opening a new position worth an estimated $65K. The largest seller was Renaissance Technologies, cutting an estimated $50.6K.
- 37 institutional investors held NanoViricides (NNVC) as of Q1 2025, up from 36 in Q4 2024.
- Funds reported $1.74M of NanoViricides stock for Q1 2025, down 17% quarter-over-quarter.
- 3 funds opened new NanoViricides positions in Q1 2025 and 2 closed out, a net change of +1 holder.
- The largest NanoViricides buyer in Q1 2025 was XTX Topco, an estimated $65K added.
- The largest NanoViricides seller in Q1 2025 was Renaissance Technologies, an estimated $50.6K sold.
Based on aggregated 13F filings for Q1 2025.